tocophersolan has been researched along with coenzyme q10 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ceresara, G; Fogagnolo, P; Lapadula, P; Orzalesi, N; Paderni, R; Rossetti, L; Sacchi, M | 1 |
| Han, HK; Shao, Y; Yang, L | 1 |
| Brenton, J; Butt, G; Cordeiro, MF; Davis, BM; Guo, L; Malaguarnera, G; Normando, EM; Pahlitzsch, M; Ravindran, N; Tian, K | 1 |
| Bettini, R; Buttini, F; Del Favero, E; Fröhlich, E; McConville, JT; Rossi, A; Rossi, F; Rossi, I; Sonvico, F; Zellnitz, S | 1 |
| Boyd, BJ; Gavin, PD; Khan, JT; Libinaki, R; Pham, A; Ramirez, G | 1 |
| Caporossi, A; Fasciani, R; Gambini, G; Tredici, C; Villano, A | 1 |
| Açıkalın, A; Dağlıoğlu, YK; Oruz, O; Polat, S; Şaker, D; Yar, K | 1 |
1 trial(s) available for tocophersolan and coenzyme q10
| Article | Year |
|---|---|
The effects of topical coenzyme Q10 and vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate after cataract surgery: a clinical and in vivo confocal study.
Topics: Administration, Topical; Aged; Cataract Extraction; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microscopy, Confocal; Ophthalmic Solutions; Polyethylene Glycols; Postoperative Care; Postoperative Complications; Retrospective Studies; Treatment Outcome; Ubiquinone; Vitamin E; Vitamins; Wound Healing | 2013 |
6 other study(ies) available for tocophersolan and coenzyme q10
| Article | Year |
|---|---|
TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10.
Topics: Administration, Oral; Animals; Antioxidants; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Humans; Liposomes; Male; Particle Size; Polyethylene Glycols; Powders; Rats; Rats, Sprague-Dawley; Ubiquinone; Vitamin E | 2015 |
Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension.
Topics: Animals; Disease Models, Animal; Male; Mitochondria; Neuroprotection; Neuroprotective Agents; Ocular Hypertension; Rats; Retinal Ganglion Cells; Treatment Outcome; Ubiquinone; Vitamin E | 2017 |
Nebulized coenzyme Q
Topics: A549 Cells; Aerosols; Antioxidants; Biological Transport; Calibration; Cell Survival; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Liberation; Drug Stability; Humans; Lecithins; Lung; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Stearates; Surface Properties; Ubiquinone; Viscosity; Vitamin E | 2018 |
Differential Effects of TPM, A Phosphorylated Tocopherol Mixture, and Other Tocopherol Derivatives as Excipients for Enhancing the Solubilization of Co-Enzyme Q10 as a Lipophilic Drug During Digestion of Lipid- Based Formulations.
Topics: Digestion; Excipients; Fasting; Intestine, Small; Phosphorylation; Solubility; Triglycerides; Ubiquinone; Vitamin E | 2019 |
Efficacy of eye drops containing crosslinked hyaluronic acid and CoQ10 in restoring ocular health exposed to chlorinated water.
Topics: Administration, Ophthalmic; Adolescent; Adult; Chloramines; Conjunctival Diseases; Corneal Diseases; Cross-Linking Reagents; Disinfectants; Drug Combinations; Humans; Hyaluronic Acid; Hyperemia; Male; Ophthalmic Solutions; Osmolar Concentration; Prospective Studies; Quality of Life; Surveys and Questionnaires; Swimming Pools; Tears; Ubiquinone; Vitamin E; Vitamins; Water Pollutants, Chemical; Young Adult | 2020 |
Histopathological effects of topical coenzyme q 10 + Vit E TPGS in experimental ischemic optic neuropathy.
Topics: Animals; Disease Models, Animal; Male; Optic Neuropathy, Ischemic; Rats; Rats, Wistar; Ubiquinone; Vitamin E | 2022 |